vs
Side-by-side financial comparison of Evaxion A/S (EVAX) and Youxin Technology Ltd (YAAS). Click either name above to swap in a different company.
Youxin Technology Ltd is the larger business by last-quarter revenue ($39.4K vs $37.0K, roughly 1.1× Evaxion A/S). Youxin Technology Ltd runs the higher net margin — -324.8% vs -13056.8%, a 12732.0% gap on every dollar of revenue.
Evaxion A/S is a Danish clinical-stage biotechnology company that leverages proprietary artificial intelligence platforms to develop targeted immunotherapies. Its core pipeline includes personalized cancer vaccines, off-the-shelf immuno-oncology treatments, and novel infectious disease therapies, advancing programs through partnerships with global pharmaceutical stakeholders.
Youxin Technology Ltd is a China-based automotive digital service provider. It operates used car trading platforms, offers new car sales support, auto financing referrals, and after-sales resource matching for consumers and auto industry participants across mainland China, focusing on optimizing vehicle transaction efficiency.
EVAX vs YAAS — Head-to-Head
Income Statement — Q2 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $37.0K | $39.4K |
| Net Profit | $-4.8M | $-127.9K |
| Gross Margin | — | 67.9% |
| Operating Margin | -11729.7% | — |
| Net Margin | -13056.8% | -324.8% |
| Revenue YoY | -76.0% | — |
| Net Profit YoY | 22.1% | — |
| EPS (diluted) | — | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q2 25 | $37.0K | $39.4K | ||
| Q2 24 | $154.0K | — | ||
| Q2 23 | $0 | — |
| Q2 25 | $-4.8M | $-127.9K | ||
| Q2 24 | $-6.2M | — | ||
| Q2 23 | $-5.7M | — |
| Q2 25 | — | 67.9% | ||
| Q2 24 | — | — | ||
| Q2 23 | — | — |
| Q2 25 | -11729.7% | — | ||
| Q2 24 | -2974.7% | — | ||
| Q2 23 | — | — |
| Q2 25 | -13056.8% | -324.8% | ||
| Q2 24 | -4024.7% | — | ||
| Q2 23 | — | — |
| Q2 25 | — | — | ||
| Q2 24 | — | — | ||
| Q2 23 | $-0.21 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $14.7M | — |
| Total DebtLower is stronger | $9.2M | — |
| Stockholders' EquityBook value | $6.2M | $-374.6K |
| Total Assets | $22.4M | $132.2K |
| Debt / EquityLower = less leverage | 1.48× | — |
8-quarter trend — quarters aligned by calendar period.
| Q2 25 | $14.7M | — | ||
| Q2 24 | $8.0M | — | ||
| Q2 23 | $7.1M | — |
| Q2 25 | $9.2M | — | ||
| Q2 24 | $8.4M | — | ||
| Q2 23 | $8.2M | — |
| Q2 25 | $6.2M | $-374.6K | ||
| Q2 24 | $1.3M | — | ||
| Q2 23 | $2.5M | — |
| Q2 25 | $22.4M | $132.2K | ||
| Q2 24 | $15.2M | — | ||
| Q2 23 | $16.8M | — |
| Q2 25 | 1.48× | — | ||
| Q2 24 | 6.72× | — | ||
| Q2 23 | 3.25× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $-88.6K |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q2 25 | — | $-88.6K | ||
| Q2 24 | — | — | ||
| Q2 23 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
